Literature DB >> 8443851

Pharmacodynamic behaviour of rocuronium in the elderly.

D R Bevan1, P Fiset, P Balendran, J C Law-Min, A Ratcliffe, F Donati.   

Abstract

This study compared the potency and time course of action of rocuronium (ORG 9426) in elderly and young patients during nitrous oxide-opioid anaesthesia. One hundred ASA physical status I-II patients (60, aged 65-80 yr, and 40, aged 20-45 yr) were studied by measuring the force of contraction of the adductor pollicis in response to train-of-four stimulation of the ulnar nerve. After induction of anaesthesia with thiopentone and maintenance with N2O/O2 and fentanyl, rocuronium 120, 160, 200, or 240 micrograms.kg-1 was administered to determine dose-response curves. When maximum block had been obtained, further rocuronium to a total of 300 micrograms.kg-1 was given. Additional doses of 100 micrograms.kg-1 were administered when the first twitch height (T1) had recovered to 25% control. At the end of surgery neuromuscular blockade was allowed, whenever possible, to recover spontaneously until T1 was 90% of control before administration of neostigmine. There was no difference in the potency of rocuronium in the elderly and the younger patients. The ED50 was 196 +/- 8 (SEE for the mean) in elderly, vs 215 +/- 17 micrograms.kg-1 in young patients (NS). When individual cumulative dose-response curves were constructed, the ED50 was 203 +/- 7 (SEM) and 201 +/- 10 micrograms.kg-1 in the elderly and the young respectively (NS). However, the onset of maximum neuromuscular block was slower in the elderly 3.7 +/- 1.1 (SD) vs 3.1 +/- 0.9 min, P < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8443851     DOI: 10.1007/BF03011309

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  30 in total

1.  The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl.

Authors:  J M Wierda; U W Kleef; L M Lambalk; W D Kloppenburg; S Agoston
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

2.  Two-dose technique to create an individual dose-response curve for atracurium.

Authors:  O A Meretoja; K Wirtavuori
Journal:  Anesthesiology       Date:  1989-05       Impact factor: 7.892

3.  Effects of ageing on the pharmacokinetics of pancuronium.

Authors:  K McLeod; C J Hull; M J Watson
Journal:  Br J Anaesth       Date:  1979-05       Impact factor: 9.166

4.  Comparison of cumulative and single bolus dose techniques for determining the potency of vecuronium.

Authors:  F M Gibson; R K Mirakhur; R S Clarke; G G Lavery
Journal:  Br J Anaesth       Date:  1985-11       Impact factor: 9.166

5.  The effects of age on the dose-response curves for vecuronium in adults.

Authors:  D A O'Hara; R J Fragen; C A Shanks
Journal:  Anesthesiology       Date:  1985-11       Impact factor: 7.892

6.  Distribution, elimination, and action of vecuronium in the elderly.

Authors:  C A Lien; R S Matteo; E Ornstein; A E Schwartz; J Diaz
Journal:  Anesth Analg       Date:  1991-07       Impact factor: 5.108

7.  Vecuronium neuromuscular blockade at the adductor muscles of the larynx and adductor pollicis.

Authors:  F Donati; C Meistelman; B Plaud
Journal:  Anesthesiology       Date:  1991-05       Impact factor: 7.892

8.  Potency of atracurium: a comparison of single dose and cumulative dose techniques.

Authors:  F M Gibson; R K Mirakhur; G G Lavery; R S Clarke
Journal:  Anesthesiology       Date:  1985-05       Impact factor: 7.892

9.  Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency?

Authors:  A F Kopman
Journal:  Anesthesiology       Date:  1989-06       Impact factor: 7.892

10.  Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agent.

Authors:  J M Wierda; A P de Wit; K Kuizenga; S Agoston
Journal:  Br J Anaesth       Date:  1990-04       Impact factor: 9.166

View more
  9 in total

Review 1.  Clinical pharmacokinetics of the newer neuromuscular blocking drugs.

Authors:  D P Atherton; J M Hunter
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  Effective method of continuous rocuronium administration based on effect-site concentrations using a pharmacokinetic/pharmacodynamic model during propofol-remifentanil anesthesia.

Authors:  Takahiro Moriyama; Akira Matsunaga; Osamu Nagata; Kei Enohata; Tomomi Kamikawaji; Erika Uchino; Yuichi Kanmura
Journal:  J Anesth       Date:  2015-03-01       Impact factor: 2.078

Review 3.  Newer neuromuscular blocking agents: how do they compare with established agents?

Authors:  H J Sparr; T M Beaufort; T Fuchs-Buder
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  General anaesthesia in elderly patients with cardiovascular disorders: choice of anaesthetic agent.

Authors:  Sangeeta Das; Kirsty Forrest; Simon Howell
Journal:  Drugs Aging       Date:  2010-04-01       Impact factor: 3.923

Review 5.  Neuromuscular transmission and its pharmacological blockade. Part 4: Use of relaxants in paediatric and elderly patients, in obstetrics, and in the intensive care unit.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

Review 6.  Clinical pharmacokinetics of rocuronium bromide.

Authors:  K S Khuenl-Brady; H Sparr
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

Review 7.  Selecting neuromuscular-blocking drugs for elderly patients.

Authors:  Tristan M Cope; Jennifer M Hunter
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  The relationship of the anthropometric variables to the infusion rate of rocuronium in the elderly.

Authors:  Bon Nyeo Koo; Sun Jun Bai; Yang-Sik Shin; Woo Chang Lee
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

9.  Rocuronium 0.3 or 0.9 mg/kg comparing onset time, duration of action, and intubating conditions in patients 80 years and older: A randomized study.

Authors:  Matias Vested; Pernille Pape; Camilla M Kristensen; Felicia Dinesen; Malene Vang; Rasmus E Christensen; Cecilie B Lindahl; Charlotte Albrechtsen; Lars S Rasmussen
Journal:  Acta Anaesthesiol Scand       Date:  2022-06-27       Impact factor: 2.274

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.